Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation.
Crippa F, Seregni E, Agresti R, Chiesa C, Pascali C, Bogni A, Decise D, De Sanctis V, Greco M, Daidone MG, Bombardieri E. Crippa F, et al. Among authors: chiesa c. Eur J Nucl Med. 1998 Oct;25(10):1429-34. doi: 10.1007/s002590050319. Eur J Nucl Med. 1998. PMID: 9818284 Clinical Trial.
The contribution of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in the preoperative detection of axillary metastases of breast cancer: the experience of the National Cancer Institute of Milan.
Crippa F, Agresti R, Donne VD, Pascali C, Bogni A, Chiesa C, De Sanctis V, Schiavini M, Decise D, Bombardieri E. Crippa F, et al. Among authors: chiesa c. Tumori. 1997 Mar-Apr;83(2):542-3. doi: 10.1177/030089169708300211. Tumori. 1997. PMID: 9226015 No abstract available.
Radiolabeled somatostaitin analogs in the treatment of neuroendocrine tumors: experience of the National Cancer Institute of Milano using high dose of 111In-pentetreotide in metastatic neuroendocrine gastroenteropancreatic tumors.
Bombardieri E, Seregni E, Savelli G, Villano C, Castellani MR, Cirillo F, Pallotti F, Fracassi S, Chiesa C, Chiti A, Bajetta E. Bombardieri E, et al. Among authors: chiesa c. J Endocrinol Invest. 2003;26(8 Suppl):63-9. J Endocrinol Invest. 2003. PMID: 15233216 Clinical Trial. No abstract available.
276 results